Pharmaceutical Crystal and Process Engineering
A special issue of Crystals (ISSN 2073-4352). This special issue belongs to the section "Industrial Crystallization".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 10984
Special Issue Editors
Interests: indursitial crystallization; crystal engineering; crystal growth; nucleation; pathological crystallization; biomineralization; enantiomers; chiral resolution; tautomers; deracemization
Interests: CFD; numerical simulation of crystallization; mixing; crystallizer modelling and design; population balance modelling
Interests: molecular self-assembly; molecular conformational flexibility; the relationship between molecular structure, crystal structure, and the properties of the materials
Interests: crystal engineering; co-crystal; drug delivery; lipid nanoparticle; targeted drug delivery; nanocrystal
Special Issue Information
Dear Colleagues,
We are delighted to invite you submit an article for a Special Issue of Crystals titled “Pharmaceutical Crystals and Process Engineering”. In focus are understandings and engineering of pharmaceutical crystals with tunable physiochemical properties and crystallization processes from the perspectives of both chemical and crystal engineering.
Crystals are the most used solid-state form in pharmaceuticals. Understanding and engineering pharmaceutical crystals with desirable physiochemical properties are essential aspects of drug development and manufacturing. Over the past decades of intense study, enormous efforts and achievements from the engineering and screening of new polymorphs to the design and development of multicomponent crystals including co-crystals and salts were made for tuning physiochemical properties such as solubility, stability, hygroscopicity, and mechanical properties. The fulfilment of these significant advances in pharmaceutical crystal development is beneficial for advancing our understanding of both crystal engineering and crystallization process engineering.
The goal of this Special Issue on “Pharmaceutical Crystals and Process Engineering” is thus to publish novel findings and engineering developments in pharmaceutical crystals and crystallization processing. This includes the design, screening, and synthesis of polymorphs, co-crystals, salts, and solvates with tunable physiochemical properties, as well as fundamental and engineering issues regarding to crystallization processes (e.g., crystal nucleation, continuous crystallization, modelling and design of crystallizers, mixing and CFD simulation of crystallization process).
The present Special Issue lists some keywords as a guide for submissions, but other contributions dealing with other innovative findings in pharmaceutical science and engineering are also welcome.
Dr. Weiwei Tang
Dr. Jingcai Cheng
Dr. Wei Du
Dr. Wei Gao
Dr. Zhengjie Meng
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Crystals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2100 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- crystal engineering
- polymorph
- co-crystals
- salts
- solvate
- crystallography
- molecular interactions
- nano-pharmacokinetics
- nanotoxicity
- crystallization
- crystal nucleation
- processing engineering
- CFD
- crystallizer modeling and design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.